BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10023787)

  • 1. Prevention of chronic lung disease in preterm infants by early postnatal dexamethasone therapy.
    Lin YJ; Yeh TF; Hsieh WS; Chi YC; Lin HC; Lin CH
    Pediatr Pulmonol; 1999 Jan; 27(1):21-6. PubMed ID: 10023787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial.
    Yeh TF; Lin YJ; Hsieh WS; Lin HC; Lin CH; Chen JY; Kao HA; Chien CH
    Pediatrics; 1997 Oct; 100(4):E3. PubMed ID: 9310536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA
    Cochrane Database Syst Rev; 2001; (2):CD001145. PubMed ID: 11405975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early postnatal dexamethasone therapy for the prevention of chronic lung disease.
    Vermont Oxford Network Steroid Study Group
    Pediatrics; 2001 Sep; 108(3):741-8. PubMed ID: 11533345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2003; (1):CD001145. PubMed ID: 12535401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants.
    Romagnoli C; Zecca E; Vento G; De Carolis MP; Papacci P; Tortorolo G
    Intensive Care Med; 1999 Jul; 25(7):717-21. PubMed ID: 10470576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2003; (1):CD001144. PubMed ID: 12535400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up.
    Romagnoli C; Zecca E; Luciano R; Torrioli G; Tortorolo G
    Pediatrics; 2002 Jun; 109(6):e85. PubMed ID: 12042579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA
    Cochrane Database Syst Rev; 2000; (2):CD001146. PubMed ID: 10796252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA
    Cochrane Database Syst Rev; 2000; (2):CD001145. PubMed ID: 10796251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.
    Gross SJ; Anbar RD; Mettelman BB
    Pediatrics; 2005 Mar; 115(3):681-7. PubMed ID: 15741372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2014 May; (5):CD001145. PubMed ID: 24825542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2003; (1):CD001146. PubMed ID: 12535402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early dexamethasone therapy in preterm infants: a follow-up study.
    Yeh TF; Lin YJ; Huang CC; Chen YJ; Lin CH; Lin HC; Hsieh WS; Lien YJ
    Pediatrics; 1998 May; 101(5):E7. PubMed ID: 9565440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial.
    Durand M; Sardesai S; McEvoy C
    Pediatrics; 1995 Apr; 95(4):584-90. PubMed ID: 7700763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on Postnatal Steroids.
    Halliday HL
    Neonatology; 2017; 111(4):415-422. PubMed ID: 28538237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA
    Cochrane Database Syst Rev; 2000; (2):CD001144. PubMed ID: 10796416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome.
    Tapia JL; Ramírez R; Cifuentes J; Fabres J; Hübner ME; Bancalari A; Mercado ME; Standen J; Escobar M
    J Pediatr; 1998 Jan; 132(1):48-52. PubMed ID: 9469999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.